Skip to main content
Premium Trial:

Request an Annual Quote

PolyOrg Licenses Rights to PNA Monomers from Copenhagen Inventor Group

NEW YORK (GenomeWeb News) — PolyOrg said today that it has licensed from the Copenhagen Inventor Group the right to make and sell PNA monomers worldwide.

PNAs are oligonucleotide analogs in which the sugar-phosphate backbone of DNA is substituted by amino-ethyl-glycine backbone. They hybridize strongly to complementary DNA or RNA but are not degraded by nucleases or proteases, the company said, and they are useful for molecular biology and diagnostics applications and antisense and anti-gene therapies.

Under the non-exclusive license, PolyOrg will initially offer Fmoc/Bhoc protected monomers, which are are compatible with "several" commercially automated DNA/Peptide/PNA synthesizers, the company said.

Financial terms of the agreement were not released.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.